These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1916649)

  • 1. Exogenous human growth hormone reduces body fat in obese women.
    Skaggs SR; Crist DM
    Horm Res; 1991; 35(1):19-24. PubMed ID: 1916649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition response to exogenous GH during training in highly conditioned adults.
    Crist DM; Peake GT; Egan PA; Waters DL
    J Appl Physiol (1985); 1988 Aug; 65(2):579-84. PubMed ID: 3170408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormone secretion.
    Crist DM; Kraner JC
    Metabolism; 1990 Dec; 39(12):1320-4. PubMed ID: 2246974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
    Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1988 Jul; 67(1):54-61. PubMed ID: 3379136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplemental growth hormone alters body composition, muscle protein metabolism and serum lipids in fit adults: characterization of dose-dependent and response-recovery effects.
    Crist DM; Peake GT; Loftfield RB; Kraner JC; Egan PA
    Mech Ageing Dev; 1991 May; 58(2-3):191-205. PubMed ID: 1875728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans.
    Snyder DK; Clemmons DR; Underwood LE
    J Clin Endocrinol Metab; 1989 Oct; 69(4):745-52. PubMed ID: 2778033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.
    Clemmons DR; Snyder DK; Williams R; Underwood LE
    J Clin Endocrinol Metab; 1987 May; 64(5):878-83. PubMed ID: 3558728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion.
    Crist DM; Peake GT; Mackinnon LT; Sibbitt WL; Kraner JC
    Metabolism; 1987 Dec; 36(12):1115-7. PubMed ID: 3683183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent lipolytic effect of exogenous growth hormone during caloric restriction.
    Snyder DK; Underwood LE; Clemmons DR
    Am J Med; 1995 Feb; 98(2):129-34. PubMed ID: 7847429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
    Clasen BF; Poulsen MM; Escande C; Pedersen SB; Møller N; Chini EN; Jessen N; Jørgensen JO
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2565-73. PubMed ID: 25050904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding.
    Di Somma C; Angrisani L; Rota F; Savanelli MC; Cascella T; Belfiore A; Orio F; Lombardi G; Colao A; Savastano S
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):393-9. PubMed ID: 18194484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone affects both adiposity and voluntary food intake in old and obese female rats.
    Malmlöf K; Din N; Johansen T; Pedersen SB
    Eur J Endocrinol; 2002 Jan; 146(1):121-8. PubMed ID: 11751077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition modulates the effects of hormone replacement therapy on growth hormone and insulin-like growth factor-I levels in postmenopausal women.
    Figueroa A; Going SB; Milliken LA; Blew R; Sharp S; Lohman TG
    Gynecol Obstet Invest; 2002; 54(4):201-6. PubMed ID: 12592062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations.
    Cohn L; Feller AG; Draper MW; Rudman IW; Rudman D
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):417-25. PubMed ID: 8287568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.